These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Dyslipidaemia, statins and rheumatoid arthritis. Nurmohamed MT; Dijkmans BA Ann Rheum Dis; 2009 Apr; 68(4):453-5. PubMed ID: 19286903 [No Abstract] [Full Text] [Related]
5. A case report of a diabetic woman with very low HDL cholesterol. Chaychi L; Kinlaw WB; Asztalos BF; Schaefer EJ J Clin Lipidol; 2010; 4(2):133-5. PubMed ID: 21122641 [No Abstract] [Full Text] [Related]
6. [Treatment with hydroxymethylglutaryl coenzyme-A-reductase inhibitors in elderly patients: is it necessary?]. Alexa ID; Panaghiu L; Ungureanu G Rev Med Chir Soc Med Nat Iasi; 2005; 109(4):721-6. PubMed ID: 16610166 [TBL] [Abstract][Full Text] [Related]
7. Residual risk and high-density lipoprotein cholesterol levels: is there a relationship? Shah PK Rev Cardiovasc Med; 2011; 12(2):e55-9. PubMed ID: 21796083 [TBL] [Abstract][Full Text] [Related]
8. Lipid abnormalities and cardiovascular risk in the elderly. Milionis HJ; Elisaf MS; Mikhailidis DP Curr Med Res Opin; 2008 Mar; 24(3):653-7. PubMed ID: 18218195 [TBL] [Abstract][Full Text] [Related]
9. The expanding role of the HMG-CoA reductase inhibitor, the most widely prescribed drug in the world. Futterman LG; Lemberg L Am J Crit Care; 2005 Nov; 14(6):555-8. PubMed ID: 16249593 [No Abstract] [Full Text] [Related]
10. [Treatment for dyslipidemias in patients with arterial hypertension]. Chazova IE; Kukharchuk VV; Ratova LG; Kaminnaia VI Ter Arkh; 2007; 79(4):53-7. PubMed ID: 17564020 [TBL] [Abstract][Full Text] [Related]
11. Treating dyslipidemia in the high-risk patient. Jones PH J Fam Pract; 2010 Feb; 59(2):E1. PubMed ID: 20141719 [TBL] [Abstract][Full Text] [Related]
12. Comments on 'when to measure lipid profile after stroke'. Ovbiagele B; Saver JL Cerebrovasc Dis; 2005; 20(3):211. PubMed ID: 16103647 [No Abstract] [Full Text] [Related]
13. Drug insight: the role of statins in combination with ezetimibe to lower LDL cholesterol. Gotto AM; Farmer JA Nat Clin Pract Cardiovasc Med; 2006 Dec; 3(12):664-72. PubMed ID: 17122799 [TBL] [Abstract][Full Text] [Related]
14. Event reduction: revisiting why we treat with statins and harnessing current evidence towards optimal therapy. Weart CW; Hogan RJ Expert Opin Pharmacother; 2011 Jan; 12(1):99-117. PubMed ID: 21108580 [TBL] [Abstract][Full Text] [Related]
15. Drugs for lipids. Treat Guidel Med Lett; 2011 Mar; 9(103):13-20. PubMed ID: 21350395 [No Abstract] [Full Text] [Related]
16. Effects of simvastatin alone versus fenofibrate alone versus simvastatin plus fenofibrate on lipoprotein subparticle profiles in patients with diabetes mellitus and mixed dyslipidemia. Athyros VG; Kakafika AI; Karagiannis A; Mikhailidis DP Am J Cardiol; 2008 Jun; 101(11):1679-80. PubMed ID: 18489951 [No Abstract] [Full Text] [Related]